The University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
Location status: Recruiting
Location contact
Belinda Hernandez, PhD, MPH
CONTACT
Laura Thormaehlen
CONTACT
NCT Number: NCT07679620
The purpose of this study is to assess the efficacy of iCHAMPSS 2.0 in impacting Reach Effectiveness Adoption Implementation Maintenance (RE-AIM) implementation outcomes, with implementation of a sexual health evidence-based program (EBP) assess iCHAMPSS 2.0's efficacy in impacting determinants of sexual health EBP implementation and to conduct a process evaluation to monitor iCHAMPSS 2.0 implementation, reach, dosage, and barriers and facilitators to implementing iCHAMPSS 2.0 during the study.
Interested in participating?
Request InfoAll sexes
Interventional
Not applicable
Houston, Texas, 77030, United States
Location status: Recruiting
Belinda Hernandez, PhD, MPH
CONTACT
Laura Thormaehlen
CONTACT
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
iCHAMPSS 2.0 is designed for Program Champions, critical to EBP use, such as district and school administrators, SHAC members (which include parents), and health and physical education teachers, who are highly motivated to promote sexual health education.
iCHAMPSS 2.0 has four features:
Time frame: From baseline to end of intervention period (about 20 to 30 months from baseline)
Time frame: From baseline to end of intervention period (about 20 to 30 months from baseline)
Time frame: From baseline to end of intervention period (about 20 to 30 months from baseline)
Time frame: From baseline to end of intervention period (about 20 to 30 months from baseline)
Time frame: From baseline to end of intervention period (about 20 to 30 months from baseline)
Time frame: From baseline to end of intervention period (about 20 to 30 months from baseline)
Time frame: From baseline to end of intervention period (about 20 to 30 months from baseline)
Time frame: From baseline to end of intervention period (about 20 to 30 months from baseline)
Time frame: From baseline to end of intervention period (about 20 to 30 months from baseline)
This is a 3 item questionnaire and each is scored form (1) Strongly disagree to (5) Strongly agree, maximum score of 15, higher score indicating worse outcome
Time frame: From baseline to end of intervention period (about 20 to 30 months from baseline)
This is a 5 item questionnaire and each is scored from (1) Strongly disagree to (5) Strongly agree maximum score 25, higher score indicating better outcome
Time frame: From baseline to end of intervention period (about 20 to 30 months from baseline)
This is a 4 item questionnaire and each is scored from (1) Strongly disagree to (5) Strongly agree, maximum score of 20, higher score indicating better better outcome
Time frame: From baseline to end of intervention period (about 20 to 30 months from baseline)
This is a 8 item questionnaire and each is scored from (1) not at all supportive to (4) very supportive , maximum score of 32 , higher score indicating better outcome
Time frame: From baseline to end of intervention period (about 20 to 30 months from baseline)
This is a 2 item questionnaire and each is scored from 1(strongly disagree) -5(strongly agree), maximum score 10, higher score indicating better outcome
Time frame: From baseline to end of intervention period (about 20 to 30 months from baseline)
This is a 5 item questionnaire and each is scored from 1(strongly disagree) -5(strongly agree), maximum score of 25, higher score indicating better outcome
Time frame: From baseline to end of intervention period (about 20 to 30 months from baseline)
This is a 4 item questionnaire and each is scored 1(strongly disagree) -5(strongly agree), maximum score 20, higher score indicating better outcome
Time frame: From baseline to end of intervention period (about 20 to 30 months from baseline)
This is a 6 item questionnaire and each is scored from 1(strongly disagree) -5(strongly agree), maximum score of 30, higher score indicating better outcome
Time frame: From baseline to end of intervention period (about 20 to 30 months from baseline)
This is a 4 item questionnaire and each is scored from 1(strongly disagree) -5(strongly agree), maximum score 20, higher score indicating better outcome
Time frame: From baseline to end of intervention period (about 20 to 30 months from baseline)
This is a 4 item questionnaire and each is scored from 1(strongly disagree) -5(strongly agree), maximum score 20, higher score indicating better outcome
Time frame: From baseline to end of intervention period (about 20 to 30 months from baseline)
This is a 4 item questionnaire and each is scored from (1) Strongly disagree to (5) Strongly agree, maximum score range of 20, higher score indicating worse outcome
Time frame: From baseline to end of intervention period (about 20 to 30 months from baseline)
This is a 19 item questionnaire and each is scored from 1(not at all confident)-4(very confident) , maximum score range of 76, higher score indicating better outcome
Time frame: From baseline to end of school year (about 7 to 12 months from baseline)
Time frame: From baseline to end of school year (about 7 to 12 months from baseline)
This will be reported categorically as less than one hour, 1-2 hours, 3-4 hours, 5-6 hours and 7 hours or more
Time frame: From baseline to end of school year (about 7 to 12 months from baseline)
Time frame: From baseline to end of school year (about 7 to 12 months from baseline)
Time frame: From baseline to end of school year (about 7 to 12 months from baseline)
Time frame: From baseline to end of school year (about 7 to 12 months from baseline)
Time frame: From baseline to end of school year (about 7 to 12 months from baseline)
Time frame: From baseline to end of school year (about 7 to 12 months from baseline)
This will be reported as a percentage
Time frame: From baseline to end of school year (about 7 to 12 months from baseline)
This will be reported as a percentage
Contact information is provided by the study sponsor or research team.
Belinda Hernandez, PhD, MPH
CONTACT
Laura Thormaehlen
CONTACT
The University of Texas Health Science Center, Houston
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07312253
Adolescent Health, Sexual Health Education
Siirt, Turkey (Türkiye)
View Trial Details